Researchers from Moffitt Cancer Center have found a new way to boost cancer immunotherapy by targeting a protein called ...
1h
News-Medical.Net on MSNTargeting MARCO enhances cancer immunotherapy effectivenessResearchers from Moffitt Cancer Center have found a new way to boost cancer immunotherapy by targeting a protein called ...
A research team led by Prof. ZENG Zhutian from the University of Science and Technology of China (USTC) identified and named ...
7d
News Medical on MSNMacrophage-targeted therapy could enhance cardiac regeneration and myocardial repairA new review published in Genes & Diseases highlights macrophage-targeted therapy as a promising frontier in cardiac regeneration and myocardial repair.
BACKGROUND: Despite the high morbidity and mortality of heart failure with preserved ejection fraction (HFpEF), treatment ...
Richard Staines spoke with Soren Bregenholt, the new CEO of Macrophage Pharma, about the company’s strategy encompassing both immune oncology and inflammatory diseases. In healthy tissues ...
Researchers from Moffitt Cancer Center have found a new way to boost cancer immunotherapy by targeting a protein called macrophage receptor with ...
Savara Inc. (Nasdaq: SVRA) (the Company), a clinical stage biopharmaceutical company focused on rare respiratory diseases, ...
Cardiovascular disease (CVD) is the leading cause of death and disease burden worldwide. Macrophages are important components of the internal immune cells, which profoundly affects the internal ...
A recent study showed that paracrine delivery of miR-21a-5p by bone marrow mesenchymal stem cells-derived apoptotic bodies ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results